Shyhmin Huang

P. Harari, Shyhmin Huang, H. Peter Rodemann, 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

EGFR Signaling and Radiation

P. Harari, Shyhmin Huang, E. F. Dunn, 2011 .

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

S. Varambally, A. Chinnaiyan, S. Tomlins, 2005, Cancer research.

Small Molecule Inhibition of MDM2–p53 Interaction Augments Radiation Response in Human Tumors

P. Harari, J. Canon, D. Francis, 2015, Molecular Cancer Therapeutics.

Enhancement of radiation response with bevacizumab

P. Harari, J. Eickhoff, E. Armstrong, 2012, Journal of experimental & clinical cancer research : CR.

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

C. Croce, L. Fattore, R. Mancini, 2017, Journal of Translational Medicine.

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models

P. Harari, C. Hullett, R. Kimple, 2015, Clinical Cancer Research.

Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development.

P. Harari, Paul M Harari, Shyhmin Huang, 2002, Seminars in radiation oncology.

Searching for Reliable Epidermal Growth Factor Receptor Response Predictors

P. Harari, Shyhmin Huang, 2004, Clinical Cancer Research.

Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition

S. Varambally, A. Chinnaiyan, S. Tomlins, 2006, International journal of cancer.

Sym004, a Novel Anti-EGFR Antibody Mixture, Augments Radiation Response in Human Lung and Head and Neck Cancers

P. Harari, M. Kragh, E. Armstrong, 2013, Molecular Cancer Therapeutics.

Large Molecule Therapeutics Sym 004 , a Novel Anti-EGFR Antibody Mixture , Augments Radiation Response in Human Lung and Head and Neck Cancers

P. Harari, M. Kragh, E. Armstrong, 2013 .

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

P. Harari, D. Wheeler, M. Iida, 2009, Cancer biology & therapy.

Immunocytokine augments local and abscopal response and animal survival when added to radiation and CTLA-4 checkpoint inhibition in a murine melanoma model

P. Harari, A. Korman, S. Gillies, 2015, Journal of Immunotherapy for Cancer.

Immunocytokine Augments the Local and Abscopal Response to Radiation and CTLA4 Checkpoint Inhibition in a Murine Melanoma Model

P. Harari, A. Korman, Z. Morris, 2015 .

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers

P. Harari, M. Sliwkowski, A. J. van der Kogel, 2015, Molecular Cancer Therapeutics.

Establishment of acquired resistance to epidermal growth factor receptor (EGFR) inhibitors in human tumor cell lines

P. Harari, P. Chinnaiyan, E. Armstrong, 2004 .

Radiation combined with EGFR signal inhibitors: head and neck cancer focus.

P. Harari, Shyhmin Huang, 2006, Seminars in radiation oncology.

Insulin growth factor 1 like receptor (IGF-1R)

P. Harari, E. Armstrong, Shyhmin Huang, 2016, BMC Cancer.

Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab

P. Harari, E. Armstrong, Shyhmin Huang, 2016, BMC Cancer.

Epidermal Growth Factor Receptor Blockade with C 225 Modulates Proliferation , Apoptosis , and Radiosensitivity in Squamous Cell Carcinomas of the Head and Neck 1

P. Harari, Shyhmin Huang, J. Bock, 1999 .

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

P. Harari, Shyhmin Huang, J. Bock, 1999, Cancer research.

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

P. Harari, D. Wheeler, T. Kruser, 2008, Oncogene.

Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.

P. Harari, Shyhmin Huang, S. Huang, 2000, Clinical Cancer Research.

Insulin growth factor 1 like receptor (IGF-1R)

P. Harari, E. Armstrong, Shyhmin Huang, 2016, BMC Cancer.

Small Molecule Inhibition of MDM2–p53 Interaction Augments Radiation Response in Human Tumors

P. Harari, J. Canon, D. Francis, 2015, Molecular Cancer Therapeutics.

Abstract 637: MEHD7945A, an EGFR/ErbB3 dual specific antibody, overcomes acquired resistance to EGFR inhibitors in head and neck and lung tumors

P. Harari, M. Sliwkowski, Shyhmin Huang, 2011 .

Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.

P. Harari, Shyhmin Huang, S. Huang, 2001, International journal of radiation oncology, biology, physics.

Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status

S. Frye, B. Hendriks, P. Harari, 2015, Molecular Cancer Therapeutics.

Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling.

P. Harari, Shyhmin Huang, S. Huang, 2001, Seminars in radiation oncology.